A Th17 signature correlates with response to dual CTLA-4 and PD-1 blockade in metastatic renal cell carcinomaSilvia Guglietta(Medical University of South Carolina), Carsten Krieg(Medical University of South Carolina)medRxivSeptember 30, 202510.1101/2025.09.29.25335360Cited by 0SaveCiteExport RISWatch citationsRelated PapersResponse and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma|Cell Reports Medicine|2021|57